期刊
ANNALS OF NEUROLOGY
卷 70, 期 6, 页码 974-985出版社
WILEY
DOI: 10.1002/ana.22645
关键词
-
资金
- NIH [NINDS 1R01NS069605]
- Burroughs Wellcome Fund [1007607.01]
- National Health and Medical Research Council of Australia [400121]
- National Health and Medical Research Council
- NIH
- Howard Hughes Medical Institute
- National Health and Medical Research Council of Australia
- NIH/NINDS [1R01NS069605]
- Health and Research Council of New Zealand
- Cure Kids (Child Health Research Foundation)
Objective: Rare copy number variants (CNVs)deletions and duplicationshave recently been established as important risk factors for both generalized and focal epilepsies. A systematic assessment of the role of CNVs in epileptic encephalopathies, the most devastating and often etiologically obscure group of epilepsies, has not been performed. Methods: We evaluated 315 patients with epileptic encephalopathies characterized by epilepsy and progressive cognitive impairment for rare CNVs using a high-density, exon-focused, whole-genome oligonucleotide array. Results: We found that 25 of 315 (7.9%) of our patients carried rare CNVs that may contribute to their phenotype, with at least one-half being clearly or likely pathogenic. We identified 2 patients with overlapping deletions at 7q21 and 2 patients with identical duplications of 16p11.2. In our cohort, large deletions were enriched in affected individuals compared to controls, and 4 patients harbored 2 rare CNVs. We screened 2 novel candidate genes found within the rare CNVs in our cohort but found no mutations in our patients with epileptic encephalopathies. We highlight several additional novel candidate genes located in CNV regions. Interpretation: Our data highlight the significance of rare CNVs in the epileptic encephalopathies, and we suggest that CNV analysis should be considered in the genetic evaluation of these patients. Our findings also highlight novel candidate genes for further study. ANN NEUROL 2011; 70: 974-985
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据